Skip to main content

Correction to: Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs

The Original Article was published on 29 August 2019

Correction to: BMC Vet Res (2019) 15:309

https://doi.org/10.1186/s12917-019-2052-0

The original article [1] contains two mistaken instances of the molecule ‘fipronil’ in the results. These should instead have stated ‘firocoxib’.

Reference

  1. de Salazar Alcalá AG, Gioda L, Dehman A, Beugnet F. Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs. BMC Vet Res. 2019;15:309. https://doi.org/10.1186/s12917-019-2052-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Frederic Beugnet.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Salazar Alcalá, A.G., Gioda, L., Dehman, A. et al. Correction to: Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs. BMC Vet Res 15, 347 (2019). https://doi.org/10.1186/s12917-019-2116-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12917-019-2116-1